Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ACCENDRA HEALTH INC/VA/OMI · Entity 6858 | Director | May 01, 2017 | May 03, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ACCENDRA HEALTH INC/VA/
Report date May 01, 2017 · Filed May 03, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,758 |
Reported balance
After 2017-05-01 transaction · row 1
1 source rowRow 1 · 2017-05-01 · Sale · Disposed 14,995 · Balance 10,758 F1: Trade occurred pursuant to a Rule 10b5-1 trading plan established by the reporting person. F2: Weighted average of the sale price range of $34.25 through $34.74 |
Filing footnotes · ownership attribution and instrument terms
F1: Trade occurred pursuant to a Rule 10b5-1 trading plan established by the reporting person.
F2: Weighted average of the sale price range of $34.25 through $34.74
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 01, 2017 Filed May 3, 2017 20:25 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 14,995 | $34.40 | $515,899.98 |
DisclosureSEC source: 0000075252-17-000071 · edgar.xml · nonDerivative · entry 1 SMITH CRAIG R · CIK 0001202787 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,758 F1 · shares: Trade occurred pursuant to a Rule 10b5-1 trading plan established by the reporting person. F2 · price: Weighted average of the sale price range of $34.25 through $34.74 Read SEC document |
| April 17, 2017 Filed Apr 18, 2017 21:19 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 20,000 | $33.79 | $675,774.00 |
DisclosureSEC source: 0000075252-17-000062 · edgar.xml · nonDerivative · entry 1 SMITH CRAIG R · CIK 0001202787 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,753 F1 · shares: Trade occurred pursuant to a Rule 10b5-1 trading plan established by the reporting person. F2 · price: Weighted average of the sale price range of $33.63 through $33.92. Read SEC document |
| February 06, 2017 Filed Feb 7, 2017 19:18 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 3,979 | $36.00 | $143,244.00 |
DisclosureSEC source: 0000075252-17-000013 · edgar.xml · nonDerivative · entry 1 SMITH CRAIG R · CIK 0001202787 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,753 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to Reporting Person. Read SEC document |
| January 23, 2017 Filed Jan 24, 2017 15:34 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 20,000 | $35.81 | $716,208.00 |
DisclosureSEC source: 0000075252-17-000008 · edgar.xml · nonDerivative · entry 1 SMITH CRAIG R · CIK 0001202787 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,732 F1 · shares: Trade occurred pursuant to a Rule 10b5-1 trading plan established by the reporting person. F2 · price: Weighted average of the sale price range of $35.56 through $36.12. Read SEC document |
| January 09, 2017 Filed Jan 10, 2017 15:17 UTC Amendment | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 25,000 | $36.22 | $905,487.50 |
DisclosureSEC source: 0000075252-17-000007 · edgar.xml · nonDerivative · entry 1 SMITH CRAIG R · CIK 0001202787 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,732 F1 · shares: Trade occurred pursuant to a Rule 10b5-1 trading plan established by the reporting person. F2 · price: Weighted average of the sale price range of $36.08 through $36.48. Read SEC document |
| January 09, 2017 Filed Jan 10, 2017 14:49 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 25,000 | $36.22 | $905,487.50 |
DisclosureSEC source: 0000075252-17-000006 · edgar.xml · nonDerivative · entry 1 SMITH CRAIG R · CIK 0001202787 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,732 F1 · price: Weighted average of the sale price range of $36.08 through $36.48. Read SEC document |
| January 05, 2017 Filed Jan 9, 2017 20:56 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GiftCommon Stock | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-17-000005 · edgar.xml · nonDerivative · entry 1 SMITH CRAIG R · CIK 0001202787 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,732 Read SEC document |
| November 08, 2016 Filed Nov 9, 2016 19:57 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GiftCommon Stock | 8,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-16-000224 · edgar.xml · nonDerivative · entry 1 SMITH CRAIG R · CIK 0001202787 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,982 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.